 high preval antibodi hepat viru patient hepatocellular carcinoma japan japan hepatocellular carcinoma hcc preval cancer fatal rate consist signific increas last decad hcc case posit hepat surfac antigen hbsag potenti role hepat viru hcv develop hcc sera hbsag-neg hcc patient district japan antibodi hcv antigen hcvab larg number patient posit hcvab comparison preval sera blood donor histori blood transfus case posit hcvab differ rate hcc patient posit hbsag neg hcvab